About Segmed
Segmed is a medical imaging data platform that supplies de identified, regulatory grade imaging datasets for AI development and clinical research. The company aggregates studies from a network of healthcare providers, de identifies them to regulatory standards, and lets customers query for specific modalities, clinical indications and findings. Datasets are delivered for model training, validation and real world evidence generation, and the Openda platform provides exploration and insight tooling on top of the data.
It is built for life sciences and pharmaceutical research teams, medical device manufacturers seeking FDA and CE clearance, technology companies training foundation models, clinical research organizations and health systems that want to contribute data. Segmed cites more than 150 million imaging studies across CT, MRI, X ray, ultrasound, PET, mammography and other modalities, sourced from more than 2,800 partner sites across five continents, with multimodal linkage to EHR records and pathology slides. Use cases include foundation model training sets assembled in days, validation cohorts for regulatory submissions and external control arms for clinical trials.
Segmed does not publish pricing. Engagements are scoped and quoted per project or as an enterprise subscription after a conversation with the sales team, and the dataset delivered depends on the modalities, indications and volumes requested.